-
Mashup Score: 8
Featuring perspectives from Dr Bita Fakhri, including the following topics: Overview of select presentations from ASH 2023; recent FDA approval of lisocabtagene maraleucel (0:00) 6-year follow-up from the Phase III CLL14 trial of first-line venetoclax/obinutuzumab versus chlorambucil/obinutuzumab for chronic lymphocytic leukemia (CLL) (7:36) Updates from ASH 2023 from the Phase III FLAIR study of minimal residual disease (MRD)-guided ibrutinib in combination with venetoclax for previously untreated CLL (13:28) 57-month follow-up from the Phase III GLOW trial of fixed-duration ibrutinib/venetoclax for previously untreated CLL (22:28) Current clinical role of MRD testing for CLL (28:11) Key findings from 5-year follow-up of the Phase II CAPTIVATE study for patents with CLL/small lymphocytic leukemia (SLL) with relapse after first-line fixed-duration ibrutinib/venetoclax (36:43) 6-year update from the Phase III ELEVATE-TN trial of acalabrutinib with or without obinutuzumab for treatment-n
Categories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4
OncLive® State of the Science Summit: Disease State, Month Day, Year. Oncology live event features research and clinical advances in oncology.
Source: event.onclive.comCategories: General Medicine News, Hem/OncsTweet-
Look forward to presenting and seeing you at this educational session chaired by Dr. Gabriel Mannis in Palo Alto on May 9! - OncLive/State of the Science Summit/Leukemia/Lymphoma/Palo Alto, CA/May 9, 2024 https://t.co/EPZdgMHw5T
-
-
Mashup Score: 0
Stanford Center for Continuing Medical Education, The Steven Coutre Review of the 65th Annual American Society of Hematology Meeting, 2/10/2024 7:00:00 AM – 2/10/2024 5:00:00 PM, The 2024 Steven Coutre Review of the 65th ASH (American Society of Hematology) Meeting is a highly anticipated event that will showcase the latest research and data on hematologic disorders. The review aims to provide healthcare professionals with updated treatment algorithms and strategies that are geared towards optimizing the care of their patients. This comprehensive review is designed to provide up-to-date and practical information to healthcare professionals who are dedicated to improving the care of their patients with hematologic disorders. By attending the Steven Coutre Review, participants will gain new insights and knowledge that can be applied to their clinical practice, ultimately leading to better patient outcomes. The conference will utilize a variety of learning modalities, including case studi
Source: stanford.cloud-cme.comCategories: General Medicine News, Hem/OncsTweet-
Come join us on Feb 10 in Half Moon Bay, CA for the Steven Coutre Review of the 65th Annual American Society of Hematology Meeting! @StanfordCancer https://t.co/7vk6OHq5Tf
-
-
Mashup Score: 0
Nikta Fakhri is adapting and extending concepts from physics to describe how tiny biological components give rise to living organisms.
Source: Quanta MagazineCategories: Hem/Oncs, Latest HeadlinesTweet-
Not pretending to fully understand the concepts discussed in this interview, but can’t help sharing my proud sister moment. @FakhriLab — Starfish Whisperer Develops a Physical Language of Life | Quanta Magazine https://t.co/NzXqEW40fS
-
-
Mashup Score: 2Copy Number Loss at Chromosome 14q11.2 Correlates With the Proportion of T Cells in Biopsies and Helps Identify T-Cell Neoplasms - PubMed - 1 year(s) ago
Analysis of copy number losses at the T-cell receptor α locus chr14q11.2 with targeted next-generation sequencing can potentially be used to estimate the proportion of T cells and detect T-cell neoplasms.
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
Glad to see this published! In search of novel ways to diagnose some challenging TCLs: Copy Number Loss at Chromosome 14q11.2 Correlates With the Proportion of T Cells in Biopsies and Helps Identify T-Cell Neoplasms - PubMed https://t.co/A1GMulI6wt
-
-
Mashup Score: 0Join our Cloud HD Video Meeting - 2 year(s) ago
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom Rooms is the original software-based conference room solution used around the world in board, conference, huddle, and training rooms, as well as executive offices and classrooms. Founded in 2011,…
Source: Zoom VideoCategories: Hem/Oncs, Latest HeadlinesTweet-
I’m attending the San Francisco Area CLL Support Group Meeting this Sunday 11/13 at 4-6 PM. We’ll discuss the most recent advances in the field and clinical trial opportunities in the area. Link below. @briankoffman https://t.co/JqiaQLksNz
-
-
Mashup Score: 2Stanford | Faculty Positions: Details - Division Chief of Hematology - Associate or Full Professor - 2 year(s) ago
Division Chief of Hematology – Associate or Full Professor Apply now Work type: University Medical Line, University Tenure Line Location: Stanford University Categories: School of Medicine The Department of Medicine at the Stanford University School of Medicine is recruiting a Division Chief of Hematology for an academic appointment as Associate or Professor of Medicine (Hematology)…
Source: facultypositions.stanford.eduCategories: Hem/Oncs, Latest HeadlinesTweet-
The @StanfordMed Hematology Division is hiring a new Chair. A truly enormous opportunity to join and lead an incredible group of people! @StanfordCancer https://t.co/XbiW6LiUmQ
-
-
Mashup Score: 2Evaluation of pulmonary toxicities in lymphoma patients receiving brentuximab vedotin - 2 year(s) ago
Published in Leukemia & Lymphoma (Ahead of Print, 2022)
Source: Taylor & FrancisCategories: Hem/Oncs, Latest HeadlinesTweet-
A big shout out to the terrific pharmacist colleagues @UCSFCancer who take every project to the finish line. @MilohemeRx https://t.co/i5lJdoGSPD
-
-
Mashup Score: 0Summary - Hematologic Malignancies Update 2022 - 2 year(s) ago
Hematologic Malignancies Update 2022. Online registration by Cvent
Source: web.cvent.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Please join us for a thorough update on hematologic malignancies organized by @ANCO_News on May 21 in Mountain View, CA. Link to register: https://t.co/s9Gk8etkqW
-
-
Mashup Score: 5
University of California, San Francisco is hiring. Apply now!
Source: aprecruit.ucsf.eduCategories: Hem/Oncs, Latest HeadlinesTweet-
Our lymphoma and cellular therapy group @UCSFCancer is looking to hire a new faculty at assistant/associate professor level. If you are interested or know of someone interested please spread the word. Happy to share more details if you’re considering. https://t.co/oAQe868rzx
-
I enjoyed my time with @DrNeilLove dissecting some of the most recent updates in CLL/SLL/Richter’s transformation! https://t.co/yoiJr49sgs